LIMINATUS PHARMA INC-CL A
LIMNNASDAQ🏆 #5060 by market capUS Equity
——
Quote unavailableTrack LIMN
Get earnings, price moves & breaking news on Telegram
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$4M
Small Cap
📈Revenue Growth (YoY)
0.0%
Slowing
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
—
Insufficient data
No chart data available for LIMN.
Trading Snapshot
- Day Range
- —
- 52-Week Range
- $2.79 – $141.50
- Volume (shares)
- —
- Avg Volume (shares)
- —
- Shares Outstanding
- 1.3M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- —
- Last Q Revenue
- —
- P/E Ratio
- -0.1
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-26.36
- Dividend Yield
- 0.00%
LIMINATUS PHARMA INC-CL A
LIMNFinancial Trends
Financial history unavailable.
StockOtter · stockotter.spaceAbout LIMINATUS PHARMA INC-CL A
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.